BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=1074297, encodeId=987710e429787, content=请问投稿模板没找到的话，就按照作者指南的要求写就行了吗？还是按照已经发表的格式写啊，完全一头雾水。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9ac25618971, createdName=ms1000001711095909, createdTime=Fri Nov 26 17:54:05 CST 2021, time=2021-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1071029, encodeId=fe1110e102959, content=想问一下大家，收药剂学方面的文章吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=af3c5597406, createdName=ms2000001168385813, createdTime=Wed Nov 17 10:27:44 CST 2021, time=2021-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067295, encodeId=3f94106e29585, content=杂志上显示3天接收的文章，会这么快吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9a8a5315883, createdName=148999f2m69暂无昵称, createdTime=Fri Nov 05 15:00:23 CST 2021, time=2021-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055160, encodeId=473c105516022, content=偏重的研究方向：肿瘤 经验分享：投稿8天了，还是with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7d7e2868906, createdName=282597582, createdTime=Sun Sep 26 21:42:24 CST 2021, time=2021-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1054793, encodeId=7c9c1054e93a5, content=这个投稿有格式要求吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc905472554, createdName=龚huping, createdTime=Sat Sep 25 21:27:08 CST 2021, time=2021-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015672, encodeId=aa1810156e2dc, content=这个杂志是按照稿号顺序审的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a85e5091452, createdName=145d4029m98暂无昵称, createdTime=Wed Sep 08 12:55:32 CST 2021, time=2021-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015008, encodeId=6b841015008b8, content=偏重的研究方向：肿瘤 经验分享：请问这个杂志收protocol吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd395586243, createdName=ms6000000773534819, createdTime=Mon Sep 06 11:44:04 CST 2021, time=2021-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004283, encodeId=70a0100428385, content=偏重的研究方向：免疫 ; 免疫学 ; microRNA 经验分享：没有做WB，有免疫组化实验结果可以不？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65ab5425857, createdName=Doctorfan, createdTime=Sat Jul 31 21:27:57 CST 2021, time=2021-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=997472, encodeId=271799e472e0, content=审稿速度:1.0 偏重的研究方向：神经退行性疾病;基础研究;信号通路 经验分享：返修一周后，2天接受。重点：文章要求新颖，否则很难接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210701/81e131cb2c2b41e3a458a3ab0ddacef3/208d36ca74cd4a5795b4c94372c3962d.jpg, createdBy=82c15538978, createdName=Therfine, createdTime=Thu Jul 08 09:52:15 CST 2021, time=2021-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=997154, encodeId=ffa999e1544b, content=偏重的研究方向：生物物理学;细胞运动;自噬 经验分享：BBRC审稿速度快，它为什么这么快？因为很多文章虽然是同行评审，但实际并上不送外审，文章基本上由编委处理。本刊的主编为来自德国马克斯-普朗克生物化学研究所的Wolfgang Baumeister博士。其研究方向为：结构生物学，生物物理学，蛋白质折叠和降解。在编委中还包括3位来自中国的科研工作者：清华大学昌增益教授、中科院广州健康所的裴端卿教授以及中国科学院深圳先进技术研究院王丽萍教授。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=[AttachmentDto(url=https://img.medsci.cn/comment/20210707/768f06f7ac7e4a17b9cb925172001003.jpeg, type=image, width=828, height=500)], authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=小小医者, createdTime=Wed Jul 07 13:09:14 CST 2021, time=2021-07-07, status=1, ipAttribution=)]

2021-11-26 ms1000001711095909

请问投稿模板没找到的话，就按照作者指南的要求写就行了吗？还是按照已经发表的格式写啊，完全一头雾水。

26 0

[GetPortalCommentsPageByObjectIdResponse(id=1074297, encodeId=987710e429787, content=请问投稿模板没找到的话，就按照作者指南的要求写就行了吗？还是按照已经发表的格式写啊，完全一头雾水。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9ac25618971, createdName=ms1000001711095909, createdTime=Fri Nov 26 17:54:05 CST 2021, time=2021-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1071029, encodeId=fe1110e102959, content=想问一下大家，收药剂学方面的文章吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=af3c5597406, createdName=ms2000001168385813, createdTime=Wed Nov 17 10:27:44 CST 2021, time=2021-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067295, encodeId=3f94106e29585, content=杂志上显示3天接收的文章，会这么快吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9a8a5315883, createdName=148999f2m69暂无昵称, createdTime=Fri Nov 05 15:00:23 CST 2021, time=2021-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055160, encodeId=473c105516022, content=偏重的研究方向：肿瘤 经验分享：投稿8天了，还是with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7d7e2868906, createdName=282597582, createdTime=Sun Sep 26 21:42:24 CST 2021, time=2021-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1054793, encodeId=7c9c1054e93a5, content=这个投稿有格式要求吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc905472554, createdName=龚huping, createdTime=Sat Sep 25 21:27:08 CST 2021, time=2021-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015672, encodeId=aa1810156e2dc, content=这个杂志是按照稿号顺序审的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a85e5091452, createdName=145d4029m98暂无昵称, createdTime=Wed Sep 08 12:55:32 CST 2021, time=2021-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015008, encodeId=6b841015008b8, content=偏重的研究方向：肿瘤 经验分享：请问这个杂志收protocol吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd395586243, createdName=ms6000000773534819, createdTime=Mon Sep 06 11:44:04 CST 2021, time=2021-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004283, encodeId=70a0100428385, content=偏重的研究方向：免疫 ; 免疫学 ; microRNA 经验分享：没有做WB，有免疫组化实验结果可以不？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65ab5425857, createdName=Doctorfan, createdTime=Sat Jul 31 21:27:57 CST 2021, time=2021-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=997472, encodeId=271799e472e0, content=审稿速度:1.0 偏重的研究方向：神经退行性疾病;基础研究;信号通路 经验分享：返修一周后，2天接受。重点：文章要求新颖，否则很难接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210701/81e131cb2c2b41e3a458a3ab0ddacef3/208d36ca74cd4a5795b4c94372c3962d.jpg, createdBy=82c15538978, createdName=Therfine, createdTime=Thu Jul 08 09:52:15 CST 2021, time=2021-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=997154, encodeId=ffa999e1544b, content=偏重的研究方向：生物物理学;细胞运动;自噬 经验分享：BBRC审稿速度快，它为什么这么快？因为很多文章虽然是同行评审，但实际并上不送外审，文章基本上由编委处理。本刊的主编为来自德国马克斯-普朗克生物化学研究所的Wolfgang Baumeister博士。其研究方向为：结构生物学，生物物理学，蛋白质折叠和降解。在编委中还包括3位来自中国的科研工作者：清华大学昌增益教授、中科院广州健康所的裴端卿教授以及中国科学院深圳先进技术研究院王丽萍教授。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=[AttachmentDto(url=https://img.medsci.cn/comment/20210707/768f06f7ac7e4a17b9cb925172001003.jpeg, type=image, width=828, height=500)], authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=小小医者, createdTime=Wed Jul 07 13:09:14 CST 2021, time=2021-07-07, status=1, ipAttribution=)]

2021-11-17 ms2000001168385813

想问一下大家，收药剂学方面的文章吗

35 0

[GetPortalCommentsPageByObjectIdResponse(id=1074297, encodeId=987710e429787, content=请问投稿模板没找到的话，就按照作者指南的要求写就行了吗？还是按照已经发表的格式写啊，完全一头雾水。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9ac25618971, createdName=ms1000001711095909, createdTime=Fri Nov 26 17:54:05 CST 2021, time=2021-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1071029, encodeId=fe1110e102959, content=想问一下大家，收药剂学方面的文章吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=af3c5597406, createdName=ms2000001168385813, createdTime=Wed Nov 17 10:27:44 CST 2021, time=2021-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067295, encodeId=3f94106e29585, content=杂志上显示3天接收的文章，会这么快吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9a8a5315883, createdName=148999f2m69暂无昵称, createdTime=Fri Nov 05 15:00:23 CST 2021, time=2021-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055160, encodeId=473c105516022, content=偏重的研究方向：肿瘤 经验分享：投稿8天了，还是with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7d7e2868906, createdName=282597582, createdTime=Sun Sep 26 21:42:24 CST 2021, time=2021-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1054793, encodeId=7c9c1054e93a5, content=这个投稿有格式要求吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc905472554, createdName=龚huping, createdTime=Sat Sep 25 21:27:08 CST 2021, time=2021-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015672, encodeId=aa1810156e2dc, content=这个杂志是按照稿号顺序审的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a85e5091452, createdName=145d4029m98暂无昵称, createdTime=Wed Sep 08 12:55:32 CST 2021, time=2021-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015008, encodeId=6b841015008b8, content=偏重的研究方向：肿瘤 经验分享：请问这个杂志收protocol吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd395586243, createdName=ms6000000773534819, createdTime=Mon Sep 06 11:44:04 CST 2021, time=2021-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004283, encodeId=70a0100428385, content=偏重的研究方向：免疫 ; 免疫学 ; microRNA 经验分享：没有做WB，有免疫组化实验结果可以不？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65ab5425857, createdName=Doctorfan, createdTime=Sat Jul 31 21:27:57 CST 2021, time=2021-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=997472, encodeId=271799e472e0, content=审稿速度:1.0 偏重的研究方向：神经退行性疾病;基础研究;信号通路 经验分享：返修一周后，2天接受。重点：文章要求新颖，否则很难接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210701/81e131cb2c2b41e3a458a3ab0ddacef3/208d36ca74cd4a5795b4c94372c3962d.jpg, createdBy=82c15538978, createdName=Therfine, createdTime=Thu Jul 08 09:52:15 CST 2021, time=2021-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=997154, encodeId=ffa999e1544b, content=偏重的研究方向：生物物理学;细胞运动;自噬 经验分享：BBRC审稿速度快，它为什么这么快？因为很多文章虽然是同行评审，但实际并上不送外审，文章基本上由编委处理。本刊的主编为来自德国马克斯-普朗克生物化学研究所的Wolfgang Baumeister博士。其研究方向为：结构生物学，生物物理学，蛋白质折叠和降解。在编委中还包括3位来自中国的科研工作者：清华大学昌增益教授、中科院广州健康所的裴端卿教授以及中国科学院深圳先进技术研究院王丽萍教授。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=[AttachmentDto(url=https://img.medsci.cn/comment/20210707/768f06f7ac7e4a17b9cb925172001003.jpeg, type=image, width=828, height=500)], authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=小小医者, createdTime=Wed Jul 07 13:09:14 CST 2021, time=2021-07-07, status=1, ipAttribution=)]

2021-11-05 148999f2m69暂无昵称

杂志上显示3天接收的文章，会这么快吗

59 0

[GetPortalCommentsPageByObjectIdResponse(id=1074297, encodeId=987710e429787, content=请问投稿模板没找到的话，就按照作者指南的要求写就行了吗？还是按照已经发表的格式写啊，完全一头雾水。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9ac25618971, createdName=ms1000001711095909, createdTime=Fri Nov 26 17:54:05 CST 2021, time=2021-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1071029, encodeId=fe1110e102959, content=想问一下大家，收药剂学方面的文章吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=af3c5597406, createdName=ms2000001168385813, createdTime=Wed Nov 17 10:27:44 CST 2021, time=2021-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067295, encodeId=3f94106e29585, content=杂志上显示3天接收的文章，会这么快吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9a8a5315883, createdName=148999f2m69暂无昵称, createdTime=Fri Nov 05 15:00:23 CST 2021, time=2021-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055160, encodeId=473c105516022, content=偏重的研究方向：肿瘤 经验分享：投稿8天了，还是with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7d7e2868906, createdName=282597582, createdTime=Sun Sep 26 21:42:24 CST 2021, time=2021-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1054793, encodeId=7c9c1054e93a5, content=这个投稿有格式要求吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc905472554, createdName=龚huping, createdTime=Sat Sep 25 21:27:08 CST 2021, time=2021-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015672, encodeId=aa1810156e2dc, content=这个杂志是按照稿号顺序审的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a85e5091452, createdName=145d4029m98暂无昵称, createdTime=Wed Sep 08 12:55:32 CST 2021, time=2021-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015008, encodeId=6b841015008b8, content=偏重的研究方向：肿瘤 经验分享：请问这个杂志收protocol吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd395586243, createdName=ms6000000773534819, createdTime=Mon Sep 06 11:44:04 CST 2021, time=2021-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004283, encodeId=70a0100428385, content=偏重的研究方向：免疫 ; 免疫学 ; microRNA 经验分享：没有做WB，有免疫组化实验结果可以不？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65ab5425857, createdName=Doctorfan, createdTime=Sat Jul 31 21:27:57 CST 2021, time=2021-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=997472, encodeId=271799e472e0, content=审稿速度:1.0 偏重的研究方向：神经退行性疾病;基础研究;信号通路 经验分享：返修一周后，2天接受。重点：文章要求新颖，否则很难接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210701/81e131cb2c2b41e3a458a3ab0ddacef3/208d36ca74cd4a5795b4c94372c3962d.jpg, createdBy=82c15538978, createdName=Therfine, createdTime=Thu Jul 08 09:52:15 CST 2021, time=2021-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=997154, encodeId=ffa999e1544b, content=偏重的研究方向：生物物理学;细胞运动;自噬 经验分享：BBRC审稿速度快，它为什么这么快？因为很多文章虽然是同行评审，但实际并上不送外审，文章基本上由编委处理。本刊的主编为来自德国马克斯-普朗克生物化学研究所的Wolfgang Baumeister博士。其研究方向为：结构生物学，生物物理学，蛋白质折叠和降解。在编委中还包括3位来自中国的科研工作者：清华大学昌增益教授、中科院广州健康所的裴端卿教授以及中国科学院深圳先进技术研究院王丽萍教授。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=[AttachmentDto(url=https://img.medsci.cn/comment/20210707/768f06f7ac7e4a17b9cb925172001003.jpeg, type=image, width=828, height=500)], authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=小小医者, createdTime=Wed Jul 07 13:09:14 CST 2021, time=2021-07-07, status=1, ipAttribution=)]

2021-09-26 282597582

偏重的研究方向：肿瘤
经验分享：投稿8天了，还是with editor

29 0

[GetPortalCommentsPageByObjectIdResponse(id=1074297, encodeId=987710e429787, content=请问投稿模板没找到的话，就按照作者指南的要求写就行了吗？还是按照已经发表的格式写啊，完全一头雾水。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9ac25618971, createdName=ms1000001711095909, createdTime=Fri Nov 26 17:54:05 CST 2021, time=2021-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1071029, encodeId=fe1110e102959, content=想问一下大家，收药剂学方面的文章吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=af3c5597406, createdName=ms2000001168385813, createdTime=Wed Nov 17 10:27:44 CST 2021, time=2021-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067295, encodeId=3f94106e29585, content=杂志上显示3天接收的文章，会这么快吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9a8a5315883, createdName=148999f2m69暂无昵称, createdTime=Fri Nov 05 15:00:23 CST 2021, time=2021-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055160, encodeId=473c105516022, content=偏重的研究方向：肿瘤 经验分享：投稿8天了，还是with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7d7e2868906, createdName=282597582, createdTime=Sun Sep 26 21:42:24 CST 2021, time=2021-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1054793, encodeId=7c9c1054e93a5, content=这个投稿有格式要求吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc905472554, createdName=龚huping, createdTime=Sat Sep 25 21:27:08 CST 2021, time=2021-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015672, encodeId=aa1810156e2dc, content=这个杂志是按照稿号顺序审的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a85e5091452, createdName=145d4029m98暂无昵称, createdTime=Wed Sep 08 12:55:32 CST 2021, time=2021-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015008, encodeId=6b841015008b8, content=偏重的研究方向：肿瘤 经验分享：请问这个杂志收protocol吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd395586243, createdName=ms6000000773534819, createdTime=Mon Sep 06 11:44:04 CST 2021, time=2021-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004283, encodeId=70a0100428385, content=偏重的研究方向：免疫 ; 免疫学 ; microRNA 经验分享：没有做WB，有免疫组化实验结果可以不？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65ab5425857, createdName=Doctorfan, createdTime=Sat Jul 31 21:27:57 CST 2021, time=2021-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=997472, encodeId=271799e472e0, content=审稿速度:1.0 偏重的研究方向：神经退行性疾病;基础研究;信号通路 经验分享：返修一周后，2天接受。重点：文章要求新颖，否则很难接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210701/81e131cb2c2b41e3a458a3ab0ddacef3/208d36ca74cd4a5795b4c94372c3962d.jpg, createdBy=82c15538978, createdName=Therfine, createdTime=Thu Jul 08 09:52:15 CST 2021, time=2021-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=997154, encodeId=ffa999e1544b, content=偏重的研究方向：生物物理学;细胞运动;自噬 经验分享：BBRC审稿速度快，它为什么这么快？因为很多文章虽然是同行评审，但实际并上不送外审，文章基本上由编委处理。本刊的主编为来自德国马克斯-普朗克生物化学研究所的Wolfgang Baumeister博士。其研究方向为：结构生物学，生物物理学，蛋白质折叠和降解。在编委中还包括3位来自中国的科研工作者：清华大学昌增益教授、中科院广州健康所的裴端卿教授以及中国科学院深圳先进技术研究院王丽萍教授。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=[AttachmentDto(url=https://img.medsci.cn/comment/20210707/768f06f7ac7e4a17b9cb925172001003.jpeg, type=image, width=828, height=500)], authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=小小医者, createdTime=Wed Jul 07 13:09:14 CST 2021, time=2021-07-07, status=1, ipAttribution=)]

2021-09-25 龚huping

这个投稿有格式要求吗？

25 0

[GetPortalCommentsPageByObjectIdResponse(id=1074297, encodeId=987710e429787, content=请问投稿模板没找到的话，就按照作者指南的要求写就行了吗？还是按照已经发表的格式写啊，完全一头雾水。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9ac25618971, createdName=ms1000001711095909, createdTime=Fri Nov 26 17:54:05 CST 2021, time=2021-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1071029, encodeId=fe1110e102959, content=想问一下大家，收药剂学方面的文章吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=af3c5597406, createdName=ms2000001168385813, createdTime=Wed Nov 17 10:27:44 CST 2021, time=2021-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067295, encodeId=3f94106e29585, content=杂志上显示3天接收的文章，会这么快吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9a8a5315883, createdName=148999f2m69暂无昵称, createdTime=Fri Nov 05 15:00:23 CST 2021, time=2021-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055160, encodeId=473c105516022, content=偏重的研究方向：肿瘤 经验分享：投稿8天了，还是with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7d7e2868906, createdName=282597582, createdTime=Sun Sep 26 21:42:24 CST 2021, time=2021-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1054793, encodeId=7c9c1054e93a5, content=这个投稿有格式要求吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc905472554, createdName=龚huping, createdTime=Sat Sep 25 21:27:08 CST 2021, time=2021-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015672, encodeId=aa1810156e2dc, content=这个杂志是按照稿号顺序审的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a85e5091452, createdName=145d4029m98暂无昵称, createdTime=Wed Sep 08 12:55:32 CST 2021, time=2021-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015008, encodeId=6b841015008b8, content=偏重的研究方向：肿瘤 经验分享：请问这个杂志收protocol吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd395586243, createdName=ms6000000773534819, createdTime=Mon Sep 06 11:44:04 CST 2021, time=2021-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004283, encodeId=70a0100428385, content=偏重的研究方向：免疫 ; 免疫学 ; microRNA 经验分享：没有做WB，有免疫组化实验结果可以不？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65ab5425857, createdName=Doctorfan, createdTime=Sat Jul 31 21:27:57 CST 2021, time=2021-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=997472, encodeId=271799e472e0, content=审稿速度:1.0 偏重的研究方向：神经退行性疾病;基础研究;信号通路 经验分享：返修一周后，2天接受。重点：文章要求新颖，否则很难接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210701/81e131cb2c2b41e3a458a3ab0ddacef3/208d36ca74cd4a5795b4c94372c3962d.jpg, createdBy=82c15538978, createdName=Therfine, createdTime=Thu Jul 08 09:52:15 CST 2021, time=2021-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=997154, encodeId=ffa999e1544b, content=偏重的研究方向：生物物理学;细胞运动;自噬 经验分享：BBRC审稿速度快，它为什么这么快？因为很多文章虽然是同行评审，但实际并上不送外审，文章基本上由编委处理。本刊的主编为来自德国马克斯-普朗克生物化学研究所的Wolfgang Baumeister博士。其研究方向为：结构生物学，生物物理学，蛋白质折叠和降解。在编委中还包括3位来自中国的科研工作者：清华大学昌增益教授、中科院广州健康所的裴端卿教授以及中国科学院深圳先进技术研究院王丽萍教授。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=[AttachmentDto(url=https://img.medsci.cn/comment/20210707/768f06f7ac7e4a17b9cb925172001003.jpeg, type=image, width=828, height=500)], authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=小小医者, createdTime=Wed Jul 07 13:09:14 CST 2021, time=2021-07-07, status=1, ipAttribution=)]

2021-09-08 145d4029m98暂无昵称

这个杂志是按照稿号顺序审的吗？

28 0

[GetPortalCommentsPageByObjectIdResponse(id=1074297, encodeId=987710e429787, content=请问投稿模板没找到的话，就按照作者指南的要求写就行了吗？还是按照已经发表的格式写啊，完全一头雾水。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9ac25618971, createdName=ms1000001711095909, createdTime=Fri Nov 26 17:54:05 CST 2021, time=2021-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1071029, encodeId=fe1110e102959, content=想问一下大家，收药剂学方面的文章吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=af3c5597406, createdName=ms2000001168385813, createdTime=Wed Nov 17 10:27:44 CST 2021, time=2021-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067295, encodeId=3f94106e29585, content=杂志上显示3天接收的文章，会这么快吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9a8a5315883, createdName=148999f2m69暂无昵称, createdTime=Fri Nov 05 15:00:23 CST 2021, time=2021-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055160, encodeId=473c105516022, content=偏重的研究方向：肿瘤 经验分享：投稿8天了，还是with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7d7e2868906, createdName=282597582, createdTime=Sun Sep 26 21:42:24 CST 2021, time=2021-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1054793, encodeId=7c9c1054e93a5, content=这个投稿有格式要求吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc905472554, createdName=龚huping, createdTime=Sat Sep 25 21:27:08 CST 2021, time=2021-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015672, encodeId=aa1810156e2dc, content=这个杂志是按照稿号顺序审的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a85e5091452, createdName=145d4029m98暂无昵称, createdTime=Wed Sep 08 12:55:32 CST 2021, time=2021-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015008, encodeId=6b841015008b8, content=偏重的研究方向：肿瘤 经验分享：请问这个杂志收protocol吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd395586243, createdName=ms6000000773534819, createdTime=Mon Sep 06 11:44:04 CST 2021, time=2021-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004283, encodeId=70a0100428385, content=偏重的研究方向：免疫 ; 免疫学 ; microRNA 经验分享：没有做WB，有免疫组化实验结果可以不？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65ab5425857, createdName=Doctorfan, createdTime=Sat Jul 31 21:27:57 CST 2021, time=2021-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=997472, encodeId=271799e472e0, content=审稿速度:1.0 偏重的研究方向：神经退行性疾病;基础研究;信号通路 经验分享：返修一周后，2天接受。重点：文章要求新颖，否则很难接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210701/81e131cb2c2b41e3a458a3ab0ddacef3/208d36ca74cd4a5795b4c94372c3962d.jpg, createdBy=82c15538978, createdName=Therfine, createdTime=Thu Jul 08 09:52:15 CST 2021, time=2021-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=997154, encodeId=ffa999e1544b, content=偏重的研究方向：生物物理学;细胞运动;自噬 经验分享：BBRC审稿速度快，它为什么这么快？因为很多文章虽然是同行评审，但实际并上不送外审，文章基本上由编委处理。本刊的主编为来自德国马克斯-普朗克生物化学研究所的Wolfgang Baumeister博士。其研究方向为：结构生物学，生物物理学，蛋白质折叠和降解。在编委中还包括3位来自中国的科研工作者：清华大学昌增益教授、中科院广州健康所的裴端卿教授以及中国科学院深圳先进技术研究院王丽萍教授。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=[AttachmentDto(url=https://img.medsci.cn/comment/20210707/768f06f7ac7e4a17b9cb925172001003.jpeg, type=image, width=828, height=500)], authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=小小医者, createdTime=Wed Jul 07 13:09:14 CST 2021, time=2021-07-07, status=1, ipAttribution=)]

2021-09-06 ms6000000773534819

偏重的研究方向：肿瘤
经验分享：请问这个杂志收protocol吗？

29 0

[GetPortalCommentsPageByObjectIdResponse(id=1074297, encodeId=987710e429787, content=请问投稿模板没找到的话，就按照作者指南的要求写就行了吗？还是按照已经发表的格式写啊，完全一头雾水。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9ac25618971, createdName=ms1000001711095909, createdTime=Fri Nov 26 17:54:05 CST 2021, time=2021-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1071029, encodeId=fe1110e102959, content=想问一下大家，收药剂学方面的文章吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=af3c5597406, createdName=ms2000001168385813, createdTime=Wed Nov 17 10:27:44 CST 2021, time=2021-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067295, encodeId=3f94106e29585, content=杂志上显示3天接收的文章，会这么快吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9a8a5315883, createdName=148999f2m69暂无昵称, createdTime=Fri Nov 05 15:00:23 CST 2021, time=2021-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055160, encodeId=473c105516022, content=偏重的研究方向：肿瘤 经验分享：投稿8天了，还是with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7d7e2868906, createdName=282597582, createdTime=Sun Sep 26 21:42:24 CST 2021, time=2021-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1054793, encodeId=7c9c1054e93a5, content=这个投稿有格式要求吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc905472554, createdName=龚huping, createdTime=Sat Sep 25 21:27:08 CST 2021, time=2021-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015672, encodeId=aa1810156e2dc, content=这个杂志是按照稿号顺序审的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a85e5091452, createdName=145d4029m98暂无昵称, createdTime=Wed Sep 08 12:55:32 CST 2021, time=2021-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015008, encodeId=6b841015008b8, content=偏重的研究方向：肿瘤 经验分享：请问这个杂志收protocol吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd395586243, createdName=ms6000000773534819, createdTime=Mon Sep 06 11:44:04 CST 2021, time=2021-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004283, encodeId=70a0100428385, content=偏重的研究方向：免疫 ; 免疫学 ; microRNA 经验分享：没有做WB，有免疫组化实验结果可以不？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65ab5425857, createdName=Doctorfan, createdTime=Sat Jul 31 21:27:57 CST 2021, time=2021-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=997472, encodeId=271799e472e0, content=审稿速度:1.0 偏重的研究方向：神经退行性疾病;基础研究;信号通路 经验分享：返修一周后，2天接受。重点：文章要求新颖，否则很难接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210701/81e131cb2c2b41e3a458a3ab0ddacef3/208d36ca74cd4a5795b4c94372c3962d.jpg, createdBy=82c15538978, createdName=Therfine, createdTime=Thu Jul 08 09:52:15 CST 2021, time=2021-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=997154, encodeId=ffa999e1544b, content=偏重的研究方向：生物物理学;细胞运动;自噬 经验分享：BBRC审稿速度快，它为什么这么快？因为很多文章虽然是同行评审，但实际并上不送外审，文章基本上由编委处理。本刊的主编为来自德国马克斯-普朗克生物化学研究所的Wolfgang Baumeister博士。其研究方向为：结构生物学，生物物理学，蛋白质折叠和降解。在编委中还包括3位来自中国的科研工作者：清华大学昌增益教授、中科院广州健康所的裴端卿教授以及中国科学院深圳先进技术研究院王丽萍教授。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=[AttachmentDto(url=https://img.medsci.cn/comment/20210707/768f06f7ac7e4a17b9cb925172001003.jpeg, type=image, width=828, height=500)], authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=小小医者, createdTime=Wed Jul 07 13:09:14 CST 2021, time=2021-07-07, status=1, ipAttribution=)]

2021-07-31 Doctorfan

偏重的研究方向：免疫 ; 免疫学 ; microRNA
经验分享：没有做WB，有免疫组化实验结果可以不？

25 0

[GetPortalCommentsPageByObjectIdResponse(id=1074297, encodeId=987710e429787, content=请问投稿模板没找到的话，就按照作者指南的要求写就行了吗？还是按照已经发表的格式写啊，完全一头雾水。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9ac25618971, createdName=ms1000001711095909, createdTime=Fri Nov 26 17:54:05 CST 2021, time=2021-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1071029, encodeId=fe1110e102959, content=想问一下大家，收药剂学方面的文章吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=af3c5597406, createdName=ms2000001168385813, createdTime=Wed Nov 17 10:27:44 CST 2021, time=2021-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067295, encodeId=3f94106e29585, content=杂志上显示3天接收的文章，会这么快吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9a8a5315883, createdName=148999f2m69暂无昵称, createdTime=Fri Nov 05 15:00:23 CST 2021, time=2021-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055160, encodeId=473c105516022, content=偏重的研究方向：肿瘤 经验分享：投稿8天了，还是with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7d7e2868906, createdName=282597582, createdTime=Sun Sep 26 21:42:24 CST 2021, time=2021-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1054793, encodeId=7c9c1054e93a5, content=这个投稿有格式要求吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc905472554, createdName=龚huping, createdTime=Sat Sep 25 21:27:08 CST 2021, time=2021-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015672, encodeId=aa1810156e2dc, content=这个杂志是按照稿号顺序审的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a85e5091452, createdName=145d4029m98暂无昵称, createdTime=Wed Sep 08 12:55:32 CST 2021, time=2021-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015008, encodeId=6b841015008b8, content=偏重的研究方向：肿瘤 经验分享：请问这个杂志收protocol吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd395586243, createdName=ms6000000773534819, createdTime=Mon Sep 06 11:44:04 CST 2021, time=2021-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004283, encodeId=70a0100428385, content=偏重的研究方向：免疫 ; 免疫学 ; microRNA 经验分享：没有做WB，有免疫组化实验结果可以不？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65ab5425857, createdName=Doctorfan, createdTime=Sat Jul 31 21:27:57 CST 2021, time=2021-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=997472, encodeId=271799e472e0, content=审稿速度:1.0 偏重的研究方向：神经退行性疾病;基础研究;信号通路 经验分享：返修一周后，2天接受。重点：文章要求新颖，否则很难接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210701/81e131cb2c2b41e3a458a3ab0ddacef3/208d36ca74cd4a5795b4c94372c3962d.jpg, createdBy=82c15538978, createdName=Therfine, createdTime=Thu Jul 08 09:52:15 CST 2021, time=2021-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=997154, encodeId=ffa999e1544b, content=偏重的研究方向：生物物理学;细胞运动;自噬 经验分享：BBRC审稿速度快，它为什么这么快？因为很多文章虽然是同行评审，但实际并上不送外审，文章基本上由编委处理。本刊的主编为来自德国马克斯-普朗克生物化学研究所的Wolfgang Baumeister博士。其研究方向为：结构生物学，生物物理学，蛋白质折叠和降解。在编委中还包括3位来自中国的科研工作者：清华大学昌增益教授、中科院广州健康所的裴端卿教授以及中国科学院深圳先进技术研究院王丽萍教授。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=[AttachmentDto(url=https://img.medsci.cn/comment/20210707/768f06f7ac7e4a17b9cb925172001003.jpeg, type=image, width=828, height=500)], authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=小小医者, createdTime=Wed Jul 07 13:09:14 CST 2021, time=2021-07-07, status=1, ipAttribution=)]

2021-07-08 Therfine

审稿速度:1.0
偏重的研究方向：神经退行性疾病;基础研究;信号通路
经验分享：返修一周后，2天接受。重点：文章要求新颖，否则很难接收。

25 0

[GetPortalCommentsPageByObjectIdResponse(id=1074297, encodeId=987710e429787, content=请问投稿模板没找到的话，就按照作者指南的要求写就行了吗？还是按照已经发表的格式写啊，完全一头雾水。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9ac25618971, createdName=ms1000001711095909, createdTime=Fri Nov 26 17:54:05 CST 2021, time=2021-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1071029, encodeId=fe1110e102959, content=想问一下大家，收药剂学方面的文章吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=af3c5597406, createdName=ms2000001168385813, createdTime=Wed Nov 17 10:27:44 CST 2021, time=2021-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067295, encodeId=3f94106e29585, content=杂志上显示3天接收的文章，会这么快吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9a8a5315883, createdName=148999f2m69暂无昵称, createdTime=Fri Nov 05 15:00:23 CST 2021, time=2021-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055160, encodeId=473c105516022, content=偏重的研究方向：肿瘤 经验分享：投稿8天了，还是with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7d7e2868906, createdName=282597582, createdTime=Sun Sep 26 21:42:24 CST 2021, time=2021-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1054793, encodeId=7c9c1054e93a5, content=这个投稿有格式要求吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc905472554, createdName=龚huping, createdTime=Sat Sep 25 21:27:08 CST 2021, time=2021-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015672, encodeId=aa1810156e2dc, content=这个杂志是按照稿号顺序审的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a85e5091452, createdName=145d4029m98暂无昵称, createdTime=Wed Sep 08 12:55:32 CST 2021, time=2021-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015008, encodeId=6b841015008b8, content=偏重的研究方向：肿瘤 经验分享：请问这个杂志收protocol吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd395586243, createdName=ms6000000773534819, createdTime=Mon Sep 06 11:44:04 CST 2021, time=2021-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004283, encodeId=70a0100428385, content=偏重的研究方向：免疫 ; 免疫学 ; microRNA 经验分享：没有做WB，有免疫组化实验结果可以不？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65ab5425857, createdName=Doctorfan, createdTime=Sat Jul 31 21:27:57 CST 2021, time=2021-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=997472, encodeId=271799e472e0, content=审稿速度:1.0 偏重的研究方向：神经退行性疾病;基础研究;信号通路 经验分享：返修一周后，2天接受。重点：文章要求新颖，否则很难接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210701/81e131cb2c2b41e3a458a3ab0ddacef3/208d36ca74cd4a5795b4c94372c3962d.jpg, createdBy=82c15538978, createdName=Therfine, createdTime=Thu Jul 08 09:52:15 CST 2021, time=2021-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=997154, encodeId=ffa999e1544b, content=偏重的研究方向：生物物理学;细胞运动;自噬 经验分享：BBRC审稿速度快，它为什么这么快？因为很多文章虽然是同行评审，但实际并上不送外审，文章基本上由编委处理。本刊的主编为来自德国马克斯-普朗克生物化学研究所的Wolfgang Baumeister博士。其研究方向为：结构生物学，生物物理学，蛋白质折叠和降解。在编委中还包括3位来自中国的科研工作者：清华大学昌增益教授、中科院广州健康所的裴端卿教授以及中国科学院深圳先进技术研究院王丽萍教授。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=[AttachmentDto(url=https://img.medsci.cn/comment/20210707/768f06f7ac7e4a17b9cb925172001003.jpeg, type=image, width=828, height=500)], authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=小小医者, createdTime=Wed Jul 07 13:09:14 CST 2021, time=2021-07-07, status=1, ipAttribution=)]

2021-07-07 小小医者

精彩评论，需要您登录查看

26 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务